Genmab A/S (GNMSF)
Key stats
Short interest · FINRA settlement 2026-06-30
- Market cap
- $16.9B
- Short % float
- 0.24%
- Days to cover
- 1000.0
- SI change
- -14.6%
Sector peers
- 0X0USDSELL0x0.ai USDCRISISQ 31$0.00
- ACAUSDSELLAcala Token USDCRISISQ -11$0.00
- ACTUSELLActuate Therapeutics IncCRISISQ -29$1.21-1.63%
- AINUSDBUYAI Network USDRECOVERYQ 6$0.01+0.00%
- AKO_BBUYRECOVERYQ 6$29.71+0.99%
- ALCUBUYBULLQ 21$11.93+0.00%
- AMRRYSELLCRISISQ 29$11.92-2.30%
- ANIUSDBUYAnime Token USDRECOVERYQ -1$0.00
- APXMBUYBULLQ 73$31.78+0.00%
- ARI10USDSELLAri10 USDCRISISQ -17$0.00
- ASPUSELLAspen Group, Inc.CRISISQ 4$0.27+0.00%
- ASTUSDSELLAirSwap USDRECOVERYQ 1$0.00
Industry peers
FMP comparable companies · ranked by market cap
- ORINYOrion Oyj$24.2B$43.02
- ALPMYAstellas Pharma Inc.$23.8B$13.29
- ALPMFAstellas Pharma Inc.$23.0B$12.85
- IVBXFInnovent Biologics, Inc.$22.3B$12.80
- WXXWYWuXi Biologics (Cayman) Inc.$20.4B$9.92
- WXIBFWuXi Biologics (Cayman) Inc.$19.1B$4.60
- GIKLYGrifols, S.A.$13.4B$5.10
- SBMFFSino Biopharmaceutical Limited$11.3B$0.64
- SBHMYSino Biopharmaceutical Limited$11.3B$12.68
- BMXXYbioMérieux S.A.$9.5B$8.03
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
